Rekah Pharmaceutical Industry Ltd. (REKA.TA)
ILA 1400.0
(0.43%)
ILA 1400.0
(0.43%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 80.2 Million ILS | 1.9% |
| 2022 | 78.7 Million ILS | 20.78% |
| 2021 | 65.16 Million ILS | -5.07% |
| 2020 | 68.64 Million ILS | 12.32% |
| 2019 | 61.11 Million ILS | -8.43% |
| 2018 | 66.74 Million ILS | -2.0% |
| 2017 | 68.1 Million ILS | 0.5% |
| 2016 | 67.76 Million ILS | -16.66% |
| 2015 | 81.3 Million ILS | 24.4% |
| 2014 | 65.35 Million ILS | -24.54% |
| 2013 | 86.61 Million ILS | 1.5% |
| 2012 | 85.33 Million ILS | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 22.93 Million ILS | 13.37% |
| 2024 Q2 | 13.61 Million ILS | -40.63% |
| 2023 Q2 | 20.98 Million ILS | 3.21% |
| 2023 Q1 | 20.32 Million ILS | 3.27% |
| 2023 Q4 | 20.23 Million ILS | 8.41% |
| 2023 FY | 80.2 Million ILS | 1.9% |
| 2023 Q3 | 18.66 Million ILS | -11.05% |
| 2022 Q3 | 19.98 Million ILS | 4.33% |
| 2022 FY | 78.7 Million ILS | 20.78% |
| 2022 Q1 | 19.88 Million ILS | 2.08% |
| 2022 Q2 | 19.15 Million ILS | -3.68% |
| 2022 Q4 | 19.68 Million ILS | -1.48% |
| 2021 Q1 | 15.6 Million ILS | 0.28% |
| 2021 Q4 | 19.47 Million ILS | 37.5% |
| 2021 Q3 | 14.16 Million ILS | -10.97% |
| 2021 FY | 65.16 Million ILS | -5.07% |
| 2021 Q2 | 15.91 Million ILS | 1.97% |
| 2020 Q2 | 15.76 Million ILS | -13.29% |
| 2020 Q1 | 18.17 Million ILS | 32.79% |
| 2020 FY | 68.64 Million ILS | 12.32% |
| 2020 Q4 | 15.56 Million ILS | -18.73% |
| 2020 Q3 | 19.14 Million ILS | 21.46% |
| 2019 Q1 | 16.82 Million ILS | 11.52% |
| 2019 FY | 61.11 Million ILS | -8.43% |
| 2019 Q4 | 13.68 Million ILS | -18.58% |
| 2019 Q3 | 16.81 Million ILS | 15.45% |
| 2019 Q2 | 14.56 Million ILS | -13.44% |
| 2018 Q4 | 15.08 Million ILS | -4.24% |
| 2018 FY | 66.74 Million ILS | -2.0% |
| 2018 Q1 | 18.12 Million ILS | 19.22% |
| 2018 Q2 | 17.77 Million ILS | -1.95% |
| 2018 Q3 | 15.75 Million ILS | -11.38% |
| 2017 FY | 68.1 Million ILS | 0.5% |
| 2017 Q1 | 15.69 Million ILS | 14.67% |
| 2017 Q2 | 19.71 Million ILS | 25.61% |
| 2017 Q3 | 17.48 Million ILS | -11.34% |
| 2017 Q4 | 15.2 Million ILS | -13.02% |
| 2016 Q2 | 17.59 Million ILS | -6.07% |
| 2016 FY | 67.76 Million ILS | -16.66% |
| 2016 Q1 | 18.72 Million ILS | 206.08% |
| 2016 Q4 | 13.68 Million ILS | -22.91% |
| 2016 Q3 | 17.75 Million ILS | 0.95% |
| 2015 FY | 81.3 Million ILS | 24.4% |
| 2015 Q4 | 6.11 Million ILS | -73.66% |
| 2015 Q3 | 23.22 Million ILS | 27.14% |
| 2015 Q2 | 18.26 Million ILS | -3.83% |
| 2015 Q1 | 18.99 Million ILS | 34.3% |
| 2014 Q2 | 20.16 Million ILS | -13.72% |
| 2014 Q4 | 14.14 Million ILS | -41.66% |
| 2014 FY | 65.35 Million ILS | -24.54% |
| 2014 Q3 | 24.24 Million ILS | 20.25% |
| 2014 Q1 | 23.36 Million ILS | 44.73% |
| 2013 FY | 86.61 Million ILS | 1.5% |
| 2013 Q2 | 22.74 Million ILS | 17.1% |
| 2013 Q3 | 21.07 Million ILS | -7.37% |
| 2013 Q4 | 16.14 Million ILS | -23.38% |
| 2013 Q1 | 19.42 Million ILS | -3.03% |
| 2012 Q4 | 20.03 Million ILS | -6.16% |
| 2012 Q3 | 21.34 Million ILS | 0.0% |
| 2012 FY | 85.33 Million ILS | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Cannabotech LTD | -1.25 Million ILA | 6480.509% |